Bill Sutherland

Stock Analyst at Benchmark

(4.16)
# 448
Out of 5,154 analysts
166
Total ratings
48.39%
Success rate
15.07%
Average return

Stocks Rated by Bill Sutherland

Cross Country Healthcare
Mar 5, 2026
Upgrades: Buy
Price Target: $14
Current: $9.82
Upside: +42.57%
Select Medical Holdings
Mar 4, 2026
Downgrades: Hold
Price Target: n/a
Current: $16.25
Upside: -
Omnicell
Feb 2, 2026
Maintains: Buy
Price Target: $50$60
Current: $41.30
Upside: +45.28%
Huron Consulting Group
Dec 24, 2025
Maintains: Buy
Price Target: $180$215
Current: $144.83
Upside: +48.45%
HeartBeam
Dec 11, 2025
Upgrades: Buy
Price Target: $8
Current: $1.40
Upside: +471.43%
Surgery Partners
Nov 11, 2025
Maintains: Buy
Price Target: $35$30
Current: $13.36
Upside: +124.55%
Healthcare Services Group
Oct 23, 2025
Maintains: Buy
Price Target: $19$24
Current: $20.65
Upside: +16.22%
agilon health
Aug 6, 2025
Maintains: Buy
Price Target: $4$1.5
Current: $0.60
Upside: +150.71%
Nutex Health
Jul 10, 2025
Reiterates: Buy
Price Target: $300
Current: $90.28
Upside: +232.30%
Quipt Home Medical
May 14, 2025
Maintains: Buy
Price Target: $6$4
Current: $3.64
Upside: +9.89%
Maintains: Buy
Price Target: $37$30
Current: $19.70
Upside: +52.28%
Reiterates: Buy
Price Target: $4.5
Current: $2.74
Upside: +64.23%
Reiterates: Hold
Price Target: n/a
Current: $21.27
Upside: -
Initiates: Buy
Price Target: $14
Current: $10.03
Upside: +39.58%